Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.
Article Title
Clinical and Microbial Insights into the Therapeutic Potential of 1-Kestose in Managing Crohn’s Disease
Authored by
Tadashi Fujii
Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan, Department of Medical Research on Prebiotics and Probiotics, Fujita Health University, Toyoake, Aichi, Japan and BIOSIS Lab. Co., Ltd., Toyoake, Aichi, Japan.
Takumi Tochio
Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan, Department of Medical Research on Prebiotics and Probiotics, Fujita Health University, Toyoake, Aichi, Japan and BIOSIS Lab. Co., Ltd., Toyoake, Aichi, Japan.
Erika Teramura
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
Masaya Sano
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
Mia Fujisawa
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
Takayoshi Suzuki
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University Hachioji Hospital, Hachioji, Japan.
Kohei Funasaka
Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.
Eizaburo Ohno
Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.
Yoshiki Hirooka
Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan, Department of Medical Research on Prebiotics and Probiotics, Fujita Health University, Toyoake, Aichi, Japan and BIOSIS Lab. Co., Ltd., Toyoake, Aichi, Japan.
Masashi Matsushima
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.